Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/13/1225   
Active ingredient: Lonafarnib
Indication: Treatment of hepatitis delta virus infection
Sponsor: Eiger Biopharmaceuticals Europe Limited
30 Upper High Street, Thame, Oxon, OX9 3EZ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/01/2014 Orphan designation EMA/OD/132/13 (2014)295 of 16/01/2014